{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-033565","form_type":"8-K","ticker":"ZVSA","cik":"0001859007","company_name":"ZyVersa Therapeutics, Inc.","filed_at":"2026-07-16T21:00:40+00:00","discovered_at":"2026-07-16T21:02:00.267161+00:00","generated_at":"2026-07-16T21:02:10.686958+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ZyVersa Therapeutics downgraded from OTCQB to OTC Pink Limited Market","bullets":["Effective July 16, 2026, ZyVersa ceased trading on OTCQB and began trading on OTC Pink Limited Market.","The move represents a downgrade in market tier, potentially reducing visibility and liquidity for the stock.","No other material events or financial updates were disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-033565","json":"https://secwatch.observer/filing/0001493152-26-033565.json","markdown":"https://secwatch.observer/filing/0001493152-26-033565.md","text":"https://secwatch.observer/filing/0001493152-26-033565.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859007/000149315226033565/0001493152-26-033565-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859007/000149315226033565/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-16T21:02:10.686958+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}